TRANSVAC is a collaborative infrastructure project funded  by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020

 

The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.

The TRANSVAC2 Consortium has set up training modules at leading European centres (in collaboration with WP18 partners) that can be combined to create customised international courses on vaccine R&D.  

TRANSVAC training module.png

Contact us

+61 (07) 3735 4433

Subscribe to our newsletter to stay up-to-date on the latest news and events